<?xml version="1.0" encoding="UTF-8"?>
<ref id="B156-pharmaceutics-12-00171">
 <label>156.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Patel</surname>
    <given-names>G.V.</given-names>
   </name>
   <name>
    <surname>Patel</surname>
    <given-names>V.B.</given-names>
   </name>
   <name>
    <surname>Pathak</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Rajput</surname>
    <given-names>S.J.</given-names>
   </name>
  </person-group>
  <article-title>Nanosuspension of efavirenz for improved oral bioavailability: Formulation optimization, in vitro, in situ and in vivo evaluation</article-title>
  <source>Drug Dev. Ind. Pharm.</source>
  <year>2014</year>
  <volume>40</volume>
  <fpage>80</fpage>
  <lpage>91</lpage>
  <pub-id pub-id-type="doi">10.3109/03639045.2012.746362</pub-id>
  <pub-id pub-id-type="pmid">23323843</pub-id>
 </element-citation>
</ref>
